High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics

Jianliang Shen, Rong Xu, Junhua Mai, Han Cheon Kim, Xiaojing Guo, Guoting Qin, Yong Yang, Joy Wolfram, Chaofeng Mu, Xiaojun Xia, Jianhua Gu, Xuewu Liu, Zong Wan Mao, Mauro Ferrari, Haifa Shen

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Gene silencing agents such as small interfering RNA (siRNA) and microRNA offer the promise to modulate expression of almost every gene for the treatment of human diseases including cancer. However, lack of vehicles for effective systemic delivery to the disease organs has greatly limited their in vivo applications. In this study, we developed a high capacity polycation- functionalized nanoporous silicon (PCPS) platform comprised of nanoporous silicon microparticles functionalized with arginine-polyethyleneimine inside the nanopores for effective delivery of gene silencing agents. Incubation of MDA-MB-231 human breast cancer cells with PCPS loaded with STAT3 siRNA (PCPS/STAT3) or GRP78 siRNA (PCPS/GRP78) resulted in 91 and 83% reduction of STAT3 and GRP78 gene expression in vitro. Treatment of cells with a microRNA-18a mimic in PCPS (PCPS/miR-18) knocked down 90% expression of the microRNA-18a target gene ATM. Systemic delivery of PCPS/STAT3 siRNA in murine model of MDA-MB-231 breast cancer enriched particles in tumor tissues and reduced STAT3 expression in cancer cells, causing significant reduction of cancer stem cells in the residual tumor tissue. At the therapeutic dosage, PCPS/STAT3 siRNA did not trigger acute immune response in FVB mice, including changes in serum cytokines, chemokines, and colony-stimulating factors. In addition, weekly dosing of PCPS/STAT3 siRNA for four weeks did not cause signs of subacute toxicity based on changes in body weight, hematology, blood chemistry, and major organ histology. Collectively, the results suggest that we have developed a safe vehicle for effective delivery of gene silencing agents.

Original languageEnglish (US)
Pages (from-to)9867-9880
Number of pages14
JournalACS Nano
Volume7
Issue number11
DOIs
StatePublished - Nov 26 2013
Externally publishedYes

Fingerprint

Silicon
RNA
genes
Small Interfering RNA
delivery
Genes
cancer
multiple docking adapters
silicon
MicroRNAs
breast
organs
Cells
vehicles
hematology
tumors
Tumors
body weight
asynchronous transfer mode
histology

Keywords

  • cancer therapy
  • delivery
  • microRNA
  • porous silicon
  • siRNA

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Shen, J., Xu, R., Mai, J., Kim, H. C., Guo, X., Qin, G., ... Shen, H. (2013). High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano, 7(11), 9867-9880. https://doi.org/10.1021/nn4035316

High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. / Shen, Jianliang; Xu, Rong; Mai, Junhua; Kim, Han Cheon; Guo, Xiaojing; Qin, Guoting; Yang, Yong; Wolfram, Joy; Mu, Chaofeng; Xia, Xiaojun; Gu, Jianhua; Liu, Xuewu; Mao, Zong Wan; Ferrari, Mauro; Shen, Haifa.

In: ACS Nano, Vol. 7, No. 11, 26.11.2013, p. 9867-9880.

Research output: Contribution to journalArticle

Shen, J, Xu, R, Mai, J, Kim, HC, Guo, X, Qin, G, Yang, Y, Wolfram, J, Mu, C, Xia, X, Gu, J, Liu, X, Mao, ZW, Ferrari, M & Shen, H 2013, 'High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics', ACS Nano, vol. 7, no. 11, pp. 9867-9880. https://doi.org/10.1021/nn4035316
Shen, Jianliang ; Xu, Rong ; Mai, Junhua ; Kim, Han Cheon ; Guo, Xiaojing ; Qin, Guoting ; Yang, Yong ; Wolfram, Joy ; Mu, Chaofeng ; Xia, Xiaojun ; Gu, Jianhua ; Liu, Xuewu ; Mao, Zong Wan ; Ferrari, Mauro ; Shen, Haifa. / High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. In: ACS Nano. 2013 ; Vol. 7, No. 11. pp. 9867-9880.
@article{66bc9e476ede4ffab5da5eab689531b4,
title = "High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics",
abstract = "Gene silencing agents such as small interfering RNA (siRNA) and microRNA offer the promise to modulate expression of almost every gene for the treatment of human diseases including cancer. However, lack of vehicles for effective systemic delivery to the disease organs has greatly limited their in vivo applications. In this study, we developed a high capacity polycation- functionalized nanoporous silicon (PCPS) platform comprised of nanoporous silicon microparticles functionalized with arginine-polyethyleneimine inside the nanopores for effective delivery of gene silencing agents. Incubation of MDA-MB-231 human breast cancer cells with PCPS loaded with STAT3 siRNA (PCPS/STAT3) or GRP78 siRNA (PCPS/GRP78) resulted in 91 and 83{\%} reduction of STAT3 and GRP78 gene expression in vitro. Treatment of cells with a microRNA-18a mimic in PCPS (PCPS/miR-18) knocked down 90{\%} expression of the microRNA-18a target gene ATM. Systemic delivery of PCPS/STAT3 siRNA in murine model of MDA-MB-231 breast cancer enriched particles in tumor tissues and reduced STAT3 expression in cancer cells, causing significant reduction of cancer stem cells in the residual tumor tissue. At the therapeutic dosage, PCPS/STAT3 siRNA did not trigger acute immune response in FVB mice, including changes in serum cytokines, chemokines, and colony-stimulating factors. In addition, weekly dosing of PCPS/STAT3 siRNA for four weeks did not cause signs of subacute toxicity based on changes in body weight, hematology, blood chemistry, and major organ histology. Collectively, the results suggest that we have developed a safe vehicle for effective delivery of gene silencing agents.",
keywords = "cancer therapy, delivery, microRNA, porous silicon, siRNA",
author = "Jianliang Shen and Rong Xu and Junhua Mai and Kim, {Han Cheon} and Xiaojing Guo and Guoting Qin and Yong Yang and Joy Wolfram and Chaofeng Mu and Xiaojun Xia and Jianhua Gu and Xuewu Liu and Mao, {Zong Wan} and Mauro Ferrari and Haifa Shen",
year = "2013",
month = "11",
day = "26",
doi = "10.1021/nn4035316",
language = "English (US)",
volume = "7",
pages = "9867--9880",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics

AU - Shen, Jianliang

AU - Xu, Rong

AU - Mai, Junhua

AU - Kim, Han Cheon

AU - Guo, Xiaojing

AU - Qin, Guoting

AU - Yang, Yong

AU - Wolfram, Joy

AU - Mu, Chaofeng

AU - Xia, Xiaojun

AU - Gu, Jianhua

AU - Liu, Xuewu

AU - Mao, Zong Wan

AU - Ferrari, Mauro

AU - Shen, Haifa

PY - 2013/11/26

Y1 - 2013/11/26

N2 - Gene silencing agents such as small interfering RNA (siRNA) and microRNA offer the promise to modulate expression of almost every gene for the treatment of human diseases including cancer. However, lack of vehicles for effective systemic delivery to the disease organs has greatly limited their in vivo applications. In this study, we developed a high capacity polycation- functionalized nanoporous silicon (PCPS) platform comprised of nanoporous silicon microparticles functionalized with arginine-polyethyleneimine inside the nanopores for effective delivery of gene silencing agents. Incubation of MDA-MB-231 human breast cancer cells with PCPS loaded with STAT3 siRNA (PCPS/STAT3) or GRP78 siRNA (PCPS/GRP78) resulted in 91 and 83% reduction of STAT3 and GRP78 gene expression in vitro. Treatment of cells with a microRNA-18a mimic in PCPS (PCPS/miR-18) knocked down 90% expression of the microRNA-18a target gene ATM. Systemic delivery of PCPS/STAT3 siRNA in murine model of MDA-MB-231 breast cancer enriched particles in tumor tissues and reduced STAT3 expression in cancer cells, causing significant reduction of cancer stem cells in the residual tumor tissue. At the therapeutic dosage, PCPS/STAT3 siRNA did not trigger acute immune response in FVB mice, including changes in serum cytokines, chemokines, and colony-stimulating factors. In addition, weekly dosing of PCPS/STAT3 siRNA for four weeks did not cause signs of subacute toxicity based on changes in body weight, hematology, blood chemistry, and major organ histology. Collectively, the results suggest that we have developed a safe vehicle for effective delivery of gene silencing agents.

AB - Gene silencing agents such as small interfering RNA (siRNA) and microRNA offer the promise to modulate expression of almost every gene for the treatment of human diseases including cancer. However, lack of vehicles for effective systemic delivery to the disease organs has greatly limited their in vivo applications. In this study, we developed a high capacity polycation- functionalized nanoporous silicon (PCPS) platform comprised of nanoporous silicon microparticles functionalized with arginine-polyethyleneimine inside the nanopores for effective delivery of gene silencing agents. Incubation of MDA-MB-231 human breast cancer cells with PCPS loaded with STAT3 siRNA (PCPS/STAT3) or GRP78 siRNA (PCPS/GRP78) resulted in 91 and 83% reduction of STAT3 and GRP78 gene expression in vitro. Treatment of cells with a microRNA-18a mimic in PCPS (PCPS/miR-18) knocked down 90% expression of the microRNA-18a target gene ATM. Systemic delivery of PCPS/STAT3 siRNA in murine model of MDA-MB-231 breast cancer enriched particles in tumor tissues and reduced STAT3 expression in cancer cells, causing significant reduction of cancer stem cells in the residual tumor tissue. At the therapeutic dosage, PCPS/STAT3 siRNA did not trigger acute immune response in FVB mice, including changes in serum cytokines, chemokines, and colony-stimulating factors. In addition, weekly dosing of PCPS/STAT3 siRNA for four weeks did not cause signs of subacute toxicity based on changes in body weight, hematology, blood chemistry, and major organ histology. Collectively, the results suggest that we have developed a safe vehicle for effective delivery of gene silencing agents.

KW - cancer therapy

KW - delivery

KW - microRNA

KW - porous silicon

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=84888868140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888868140&partnerID=8YFLogxK

U2 - 10.1021/nn4035316

DO - 10.1021/nn4035316

M3 - Article

C2 - 24131405

AN - SCOPUS:84888868140

VL - 7

SP - 9867

EP - 9880

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 11

ER -